HK1244703A1 - 一種含有咪唑啉類衍生物的藥物組合物 - Google Patents
一種含有咪唑啉類衍生物的藥物組合物Info
- Publication number
- HK1244703A1 HK1244703A1 HK18104328.5A HK18104328A HK1244703A1 HK 1244703 A1 HK1244703 A1 HK 1244703A1 HK 18104328 A HK18104328 A HK 18104328A HK 1244703 A1 HK1244703 A1 HK 1244703A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- composition containing
- imidazoline derivative
- containing imidazoline
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610093969 | 2016-02-19 | ||
PCT/CN2017/073868 WO2017140253A1 (zh) | 2016-02-19 | 2017-02-17 | 一种含有咪唑啉类衍生物的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1244703A1 true HK1244703A1 (zh) | 2018-08-17 |
Family
ID=59624768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18104328.5A HK1244703A1 (zh) | 2016-02-19 | 2018-03-29 | 一種含有咪唑啉類衍生物的藥物組合物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US10588978B2 (zh) |
EP (1) | EP3417857B1 (zh) |
JP (1) | JP6968075B2 (zh) |
KR (1) | KR20180109991A (zh) |
CN (1) | CN107530325B (zh) |
AU (1) | AU2017220970B2 (zh) |
BR (1) | BR112018015370A2 (zh) |
CA (1) | CA3014088A1 (zh) |
HK (1) | HK1244703A1 (zh) |
MX (1) | MX2018009742A (zh) |
RU (1) | RU2749135C2 (zh) |
TW (1) | TWI732822B (zh) |
WO (1) | WO2017140253A1 (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2375046C2 (ru) * | 2004-10-25 | 2009-12-10 | Джапан Тобакко Инк. | Твердый состав с улучшенными растворимостью и стабильностью и способ его получения |
MX2011007771A (es) * | 2009-01-21 | 2011-08-12 | Hoffmann La Roche | Composiciones farmaceuticas que comprenden un profarmaco inhibidor de la polimerasa del virus de la hepatitis c (hcv). |
RU2453315C2 (ru) * | 2010-08-17 | 2012-06-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения аллергических заболеваний |
KR102189940B1 (ko) * | 2012-09-04 | 2020-12-14 | 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 | 이미다졸린 유도체, 이의 제조 방법, 및 이들의 의약에서의 용도 |
CN105030685B (zh) * | 2015-07-21 | 2018-02-27 | 福格森(武汉)生物科技股份有限公司 | 一种恩杂鲁胺固体分散体口服制剂 |
-
2017
- 2017-02-17 BR BR112018015370-2A patent/BR112018015370A2/zh active Search and Examination
- 2017-02-17 EP EP17752685.2A patent/EP3417857B1/en active Active
- 2017-02-17 KR KR1020187025162A patent/KR20180109991A/ko not_active Application Discontinuation
- 2017-02-17 WO PCT/CN2017/073868 patent/WO2017140253A1/zh active Application Filing
- 2017-02-17 US US16/077,610 patent/US10588978B2/en not_active Expired - Fee Related
- 2017-02-17 CA CA3014088A patent/CA3014088A1/en active Pending
- 2017-02-17 RU RU2018129762A patent/RU2749135C2/ru active
- 2017-02-17 MX MX2018009742A patent/MX2018009742A/es active IP Right Grant
- 2017-02-17 CN CN201780001360.5A patent/CN107530325B/zh active Active
- 2017-02-17 JP JP2018537445A patent/JP6968075B2/ja active Active
- 2017-02-17 AU AU2017220970A patent/AU2017220970B2/en active Active
- 2017-02-18 TW TW106105458A patent/TWI732822B/zh active
-
2018
- 2018-03-29 HK HK18104328.5A patent/HK1244703A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA3014088A1 (en) | 2017-08-24 |
RU2749135C2 (ru) | 2021-06-04 |
TWI732822B (zh) | 2021-07-11 |
US20190038755A1 (en) | 2019-02-07 |
KR20180109991A (ko) | 2018-10-08 |
CN107530325B (zh) | 2021-02-23 |
CN107530325A (zh) | 2018-01-02 |
WO2017140253A1 (zh) | 2017-08-24 |
AU2017220970A1 (en) | 2018-08-02 |
AU2017220970B2 (en) | 2021-12-16 |
EP3417857A1 (en) | 2018-12-26 |
BR112018015370A2 (zh) | 2018-12-18 |
EP3417857B1 (en) | 2023-07-19 |
MX2018009742A (es) | 2018-11-09 |
JP6968075B2 (ja) | 2021-11-17 |
RU2018129762A3 (zh) | 2020-03-19 |
US10588978B2 (en) | 2020-03-17 |
EP3417857A4 (en) | 2019-10-23 |
TW201729805A (zh) | 2017-09-01 |
JP2019505526A (ja) | 2019-02-28 |
RU2018129762A (ru) | 2020-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360B (en) | Pharmaceutical composition | |
IL265260B (en) | pharmaceutical preparations | |
IL271986B1 (en) | pharmaceutical preparation | |
IL262654A (en) | Pharmacy preparation | |
IL265349A (en) | Pharmaceutical composition | |
GB201712159D0 (en) | Pharmaceutical composition | |
RS59626B1 (sr) | Farmaceutska kompozicija koja sadrži mirabegron | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201719447D0 (en) | Pharmaceutical composition | |
IL272419A (en) | Pharmaceutical composition | |
IL267136A (en) | Pharmaceutical composition containing celecoxib | |
PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
GB201615917D0 (en) | Pharmaceutical composition | |
EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
IL263999A (en) | Pharmaceutical compositions | |
GB201615910D0 (en) | Pharmaceutical composition | |
GB201615914D0 (en) | Pharmaceutical composition | |
IL265436B (en) | Pharmacy preparation | |
ZA201705782B (en) | Pharmaceutical compositions | |
PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
HK1244703A1 (zh) | 一種含有咪唑啉類衍生物的藥物組合物 | |
IL265428A (en) | Pharmaceutical composition | |
PT3476391T (pt) | Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq | |
PT3329939T (pt) | Composição farmacêutica sólida à prova de abuso | |
GB201708328D0 (en) | Pharmaceutical composition |